Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12624000915550p
Ethics application status
Not yet submitted
Date submitted
5/06/2024
Date registered
29/07/2024
Date last updated
29/07/2024
Date data sharing statement initially provided
29/07/2024
Date results provided
29/07/2024
Type of registration
Prospectively registered
Titles & IDs
Public title
Comparing two weight-based hypoglycaemia treatment protocols in children and teenagers using insulin pumps at the 2025 diabetes camp.
Query!
Scientific title
Comparative Efficacy of 0.15 Grams of Glucose in Children Using Automated Insulin Delivery Pumps vs 0.3 Grams of Glucose in Children Using Non-Automated Pumps for Treating Hypoglycaemia at a Diabetes Camp
Query!
Secondary ID [1]
312257
0
nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
CE0.15G
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
hypoglycaemia
333974
0
Query!
Type 1 Diabetes
333975
0
Query!
Condition category
Condition code
Metabolic and Endocrine
330642
330642
0
0
Query!
Diabetes
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
This will be a non-randomized, interventional trial conducted at the 2025 summer camp for children with Type 1 diabetes in accordance with the Diabetes New Zealand Camping Guidelines (2020). The study will include two experimental groups based on the type of insulin delivery system they use. The participants are Children and Teenagers aged 8 -17 with a diagnosis of Type 1 diabetes attending the camp. Each participant will use either Automated Insulin Delivery pumps (AID) or non-automated insulin pumps or multiple daily injections (MDI) to manage their Type 1 diabetes.. The two interventional groups are those participants using either the Multiple Daily Injection (MDI) and non Automated Insulin Delivery (AID) system regimens or the AID system. The exclusion criteria are children with other chronic illnesses or those using medications that interfere with glucose metabolism. A total of 50 participants will be recruited and assigned to groups Camp Group Leaders for supervision as per normal diabetes camp guidelines ( please see Guidelines for Camp Leaders and DNZ Camping Guidelines). Participants will be assigned to receive 0.15 grams/kg of glucose hypoglycaemia treatment group for those using AID pumps or 0.3 grams/kg of glucose (for those using non- AID pumps or MDI regimen - upon experiencing a hypoglycaemic episode (blood glucose level less than 4.0mmol/L) - please see Diabetes Camp Hypoglycaemia and Hyperglycaemia Guidelines. Each participant will have their individualised quantity of glucose preparation calculated by the Principal Investigator before the beginning of the camp and each Group Leader will be trained the week before camp (please see 2022 Camp Group Leader Guidelines. Participants weight will be obtained from the last diabetes clinic letter of 2024. Baseline data collection is a normal part of diabetes camp procedure and recorded on their specific camp files and blood glucose recording charts. Blood glucose levels will be monitored regularly throughout the camp using continuous glucose monitoring (CGM) systems and finger-prick testing as prescribed. Hypoglycaemia episodes will be identified using CGM and confirmed with finger-prick check. Upon confirmation of hypoglycaemia, participants will receive the assigned (individualised) dose of glucose based on their insulin delivery system. Blood glucose levels will be rechecked at 15 minutes post-administration - according to the attached Diabetes Camp Hypoglycaemia and Hyperglycaemia Guidelines and the time of the day.
The Primary Outcome will be the time to normalization of blood glucose levels (less than 4.0mmol/L). The Secondary Outcomes is the incidence of rebound hyperglycaemia (blood glucose greater than 10mmol/L within 2 hours post-treatment), adverse effects, and practicality of administration
Query!
Intervention code [1]
328964
0
Treatment: Other
Query!
Comparator / control treatment
All participants have Type 1 diabetes. The control group are those on multiple daily injections or non-sensor augmented pumps using the standard protocol 0. 0.3 grams glucose/ kg of body weight to treat a hypoglycaemia episode. The treatment group are those participants on Sensor Augmented pumps and will receive the recommended reduced dose of glucose treatment - we hypothesise the is be 0.15 grams/kg of body weight.
Query!
Control group
Dose comparison
Query!
Outcomes
Primary outcome [1]
338386
0
The time to normalization of blood glucose levels (less than 4.0mmol/L).
Query!
Assessment method [1]
338386
0
Each Camp group Leader has a cell phone and will be asked to time 15 minutes on their phone timer before rechecking blood glucose with a finger prick.
Query!
Timepoint [1]
338386
0
Timing will commence once the child/teen has begun to consume the glucose and will stop once the blood glucose has reached 4.0mmol/L . Blood glucose leads sensor glucose so timing will not be reliant on sensor glucose reaching above 4.0mmol/L. Finger prick samples will be taken at 15 minute intervals.
Query!
Secondary outcome [1]
435729
0
The incidence of rebound hyperglycaemia (blood glucose greater than 10mmol/L within 2 hours post-treatment).
Query!
Assessment method [1]
435729
0
The number of events treated which resulted in a sensor glucose greater than 10mmol/L. This will be reviewed following the completion of the camp and parents can upload the child's/teen's pump at home to Glooko (the standard clinical database).
Query!
Timepoint [1]
435729
0
Following completion of the camp.
Query!
Eligibility
Key inclusion criteria
All participants selected by diabetes New Zealand selection committee being eligible to attend the 2025 children's and teenager's diabetes camp at El Rancho, Waikanae , NZ.
Query!
Minimum age
8
Years
Query!
Query!
Maximum age
17
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
None
Query!
Study design
Purpose of the study
Educational / counselling / training
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
The data (The normal camp recording sheets) will be analyzed using ‘R’ software. Descriptive statistics will summarize baseline characteristics. Independent t-tests will compare the mean time to normalization between the two groups. Chi-square tests will assess differences in the incidence of rebound hyperglycaemia and adverse effects.
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
6/01/2025
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
10/01/2025
Query!
Actual
Query!
Date of last data collection
Anticipated
10/01/2025
Query!
Actual
Query!
Sample size
Target
50
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
26358
0
New Zealand
Query!
State/province [1]
26358
0
Wellington
Query!
Country [2]
26359
0
New Zealand
Query!
State/province [2]
26359
0
Wellington
Query!
Funding & Sponsors
Funding source category [1]
316637
0
Charities/Societies/Foundations
Query!
Name [1]
316637
0
Diabetes New Zealand
Query!
Address [1]
316637
0
Query!
Country [1]
316637
0
New Zealand
Query!
Primary sponsor type
Hospital
Query!
Name
Capital & Coast Health, Wellington.
Query!
Address
Query!
Country
New Zealand
Query!
Secondary sponsor category [1]
319266
0
None
Query!
Name [1]
319266
0
Query!
Address [1]
319266
0
Query!
Country [1]
319266
0
Query!
Ethics approval
Ethics application status
Not yet submitted
Query!
Ethics committee name [1]
315419
0
Central Health and Disability Ethics Committee
Query!
Ethics committee address [1]
315419
0
https://ethics.health.govt.nz/about/central-health-and-disability-ethics-committee/
Query!
Ethics committee country [1]
315419
0
New Zealand
Query!
Date submitted for ethics approval [1]
315419
0
27/08/2024
Query!
Approval date [1]
315419
0
Query!
Ethics approval number [1]
315419
0
Query!
Summary
Brief summary
Hypoglycaemia is a critical concern for children with Type 1 diabetes, especially in active settings such as camps. This study aims to compare the efficacy of administering 0.15 grams of glucose/kg in children using automated insulin delivery (AID) pumps versus to the now standard protocol of using 0.3 grams of glucose/kg in children using non-automated insulin pumps during hypoglycaemic episodes. The goal is to determine the optimal treatment strategy that efficiently raises blood glucose levels without causing rebound hyperglycaemia, considering the different insulin management technologies.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
134646
0
Mr Lindsay McTavish
Query!
Address
134646
0
Health New Zealand - Te Whata Ora Capital & Coast Health; 66 Ridderford St; Newtown; Wellington 6021.
Query!
Country
134646
0
New Zealand
Query!
Phone
134646
0
+64 021544586
Query!
Fax
134646
0
Query!
Email
134646
0
[email protected]
Query!
Contact person for public queries
Name
134647
0
Lindsay McTavish
Query!
Address
134647
0
Health New Zealand - Te Whata Ora Capital & Coast Health; 66 Ridderford St; Newtown; Wellington 6021.
Query!
Country
134647
0
New Zealand
Query!
Phone
134647
0
+64 021544586
Query!
Fax
134647
0
Query!
Email
134647
0
[email protected]
Query!
Contact person for scientific queries
Name
134648
0
Lindsay McTavish
Query!
Address
134648
0
Health New Zealand - Te Whata Ora Capital & Coast Health; 66 Ridderford St; Newtown; Wellington 6021.
Query!
Country
134648
0
New Zealand
Query!
Phone
134648
0
+64 021544586
Query!
Fax
134648
0
Query!
Email
134648
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Data will only be available to parents, study team and clinical people responsible for the care of the participant.
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
23856
Other
This is an updated protocol of the proposed resear...
[
More Details
]
387897-(Uploaded-23-07-2024-11-35-19)-2025 Camp Research Proposal V3..docx
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF